Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)

CUSIP: 86366E106

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Ordinary Shares, par value $0.0001 per share
Shares outstanding
213,001,347
Total 13F shares
14,419,544
Share change
+14,419,544
Total reported value
$343,038,725
Price per share
$23.79
Number of holders
38
Value change
+$343,038,726
Number of buys
38

Quarterly Holders Quick Answers

What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Ramy Farid
3/4/5
Director —
mixed-class rows
3,535,495
mixed-class rows
 $17,176,500 — 07 Feb 2023
3/4/5
Melita Sun Jung
3/4/5
Chief Business Officer —
class O/S missing
1,000
 $62,460 — 07 Feb 2023
3/4/5
FIL Ltd
3/4/5
Other* —
class O/S missing
6,473,761
 — — 07 Feb 2023
3/4/5

Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q1 2023

As of 31 Mar 2023, Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,419,544 shares. The largest 10 holders included Deep Track Capital, LP, BVF INC/IL, FMR LLC, FEDERATED HERMES, INC., DRIEHAUS CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, Casdin Capital, LLC, T. Rowe Price Investment Management, Inc., Cormorant Asset Management, LP, and BlackRock Inc.. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2023 vs Q4 2025 Across Filers

Q4 2025 holders
197
Q1 2023 holders
38
Holder diff
-159
Investor Q4 2025 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .